G3O.F S.M.A.I.O S.A.

Healthcare Health Information Services Frankfurt Exchange
4.12 EUR
Close of Nov 12, 2026
4.12 8.92
Market cap
EUR 25.6M
P/E
-
P/B
3.10x
ROE
-37.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is G3O.F undervalued?

Graham number

The Graham number of S.M.A.I.O S.A. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

S.M.A.I.O S.A. fundamental analysis

No fundamental analysis for S.M.A.I.O S.A. yet.

S.M.A.I.O S.A. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About S.M.A.I.O S.A.

S.M.A.I.O S.A. provides software, implantable devices, and associated services for the surgical treatment of spinal deformities. It offers solutions for surgeons, including programs for training, assistance with surgical planning based on KEOPS database. The company also offers solutions, such as i-PLAN platform, a surgical planning solution; i-PERFORM, an assisted execution of the surgical procedure based point by point on the sheet; i-CHECK to measure and monitor the final…

Full company profile